-
13:00
-13:07
Moderately hypofractionated online adaptive chemoradiotherapy for cervical cancer: prospective clinical outcomes and comparative analysis with conventional fractionation
-
13:07
-13:14
CYP4A22-AS1 controls YBX1 nuclear accumulation to promote metabolic adaptation and radioresistance in cervical adenocarcinoma
-
13:14
-13:21
CT-based brachytherapy with MRI correlation in cervical cancer: validation of the ≥85 Gy EQD₂ benchmark in an Asian cohort
-
13:21
-13:28
Modified cesarean radical hysterectomy for cervical cancer during pregnancy: perioperative outcomes and oncologic safety
-
13:28
-13:35
Initial treatment and survival in regional node-negative cervical cancer aligned with FIGO 2009 IB2/IIA2 and 2018 IB3/IIA2
-
13:35
-13:42
Dosimetric benefits and target-quality trade-offs of proton therapy in cervical cancer: a comparison with VMAT and IMRT
-
13:42
-13:49
Radiotherapy‑guided surgical strategy for post‑hysterectomy vaginal intraepithelial neoplasia secondary to cervical cancer
-
13:49
-13:56
An optimized CT-guided brachytherapy workflow for cervical cancer: a retrospective study with simulation-based comparison

